HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ragg, S. J. Articles by Ochi, A. Search for Related Content PubMed PubMed Citation Articles by Ragg, S. J. Articles by Ochi, A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB 12-O-TETRADECANOYLPHORBOL-13-ACETATE

The Mitogen-Activated Protein Kinase Pathway Inhibits Ceramide-Induced Terminal Differentiation of a Human Monoblastic Leukemia Cell Line, U937¹

Scott J. Ragg^*, Shuji Kaga^*, Karen A. Berg and Atsuo Ochi^2,*,

^* John P. Robarts Research Institute and Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada

This communication describes an extracellular signal-regulated kinase kinase (MEK)-dependent signal transduction pathway that prevents the terminal differentiation of a hemopoietic cell line. Both PMA and the cell-permeable ceramide, C₂-ceramide, caused differentiation of U937 cells, but with distinct cell morphology and CD11b/CD14 surface expression. While PMA activated extracellular signal-regulated kinase (ERK), a downstream kinase of Raf-MEK signaling, C₂-ceramide activated c-Jun NH₂-terminal kinase (JNK), an anchor kinase of stress-induced signaling. Furthermore, only C₂-ceramide stimulated an induction of cell cycle arrest that was associated with stable expression of p21^CIP1 and retinoblastoma nuclear phosphoprotein dephosphorylation. Expression of p21^CIP1 and JNK activation were also observed in sphingosine-treated cells, whereas sphingosine did not induce detectable differentiation. Concomitant stimulation with C₂-ceramide and PMA resulted in the PMA phenotype, and cell cycle arrest was absent. ERK activation was enhanced by C₂-ceramide plus PMA stimulation, whereas the activation of JNK was aborted. Strikingly, the inhibition of MEK with PD98059 altered the phenotype of C₂-ceramide- and PMA-stimulated U937 cells to that of cells treated with C₂-ceramide alone. Thus, ERK and JNK pathways deliver distinct signals, and the ERK pathway is dominant to the JNK cascade. Furthermore, differentiation and cell cycle arrest caused by C₂-ceramide rely on independent signaling pathways, and JNK is an unlikely signaling element for this differentiation. Importantly, during C₂-ceramide and PMA costimulation, the JNK pathway is not simply blocked by ERK activation; rather, cross-talk between these MAP kinase pathways acts to simultaneously augment ERK activity and down-regulate JNK activity.

This article has been cited by other articles:

				B. Liu, Y. Lin, A. Darwanto, X. Song, G. Xu, and K. Zhang Identification and Characterization of Propionylation at Histone H3 Lysine 23 in Mammalian Cells J. Biol. Chem., November 20, 2009; 284(47): 32288 - 32295. [Abstract] [Full Text] [PDF]

				S. Mebarek, H. Komati, F. Naro, C. Zeiller, M. Alvisi, M. Lagarde, A.-F. Prigent, and G. Nemoz Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation J. Cell Sci., February 1, 2007; 120(3): 407 - 416. [Abstract] [Full Text] [PDF]

				T. E. Battle and A. Yen Ectopic Expression of CXCR5/BLR1 Accelerates Retinoic Acid- and Vitamin D3-Induced Monocytic Differentiation of U937 Cells Experimental Biology and Medicine, October 1, 2002; 227(9): 753 - 762. [Abstract] [Full Text] [PDF]

				F. Ciacci-Woolwine, P. F. McDermott, and S. B. Mizel Induction of Cytokine Synthesis by Flagella from Gram-Negative Bacteria May Be Dependent on the Activation or Differentiation State of Human Monocytes Infect. Immun., October 1, 1999; 67(10): 5176 - 5185. [Abstract] [Full Text] [PDF]

				Y. Kanatani, T. Kasukabe, J. Okabe-Kado, Y. Yamamoto-Yamaguchi, N. Nagata, K. Motoyoshi, and Y. Honma Role of CD14 Expression in the Differentiation-Apoptosis Switch in Human Monocytic Leukemia Cells Treated with 1{{alpha}},25-Dihydroxyvitamin D3 or Dexamethasone in the Presence of Transforming Growth Factor {beta} Cell Growth Differ., October 1, 1999; 10(10): 705 - 712. [Abstract] [Full Text]